Given the unique attributes of biotechnology, the traditional evaluation methods are difficult to adapt to investment assessment of biotechnology, with poor forecast performance.
鉴于生物技术的特有属性，传统评估方法难以适应生物技术风险投资项目评估的需要，预测性能较差。
Given the unique attributes of biotechnology, the traditional evaluation methods are difficult to adapt to investment assessment of biotechnology, with poor forecast performance.
鉴于生物技术的特有属性，传统评估方法难以适应生物技术风险投资项目评估的需要，预测性能较差。
应用推荐